Feature Story: |
Medtronic Acquires Gastrointestinal Diagnostic Developer Crospon in Deal Worth $45 Million |
Medtronic has reportedly acquired gastrointestinal disorder diagnostic company Crospon in a deal that could be worth as much as $45 million (EU €38 million), according to a Times UK report.
The Galway, Ireland-based developer was founded in 2006 by current chief exec John O’Dea, and is looking to develop tools to more effectively examine and possibly treat gastrointestinal disorders, according to the report.
The company produces endoscopic diagnostics, including...
Read more about this acquisition
|
|
Natick-based Allurion Technologies has developed a swallowable gastric balloon and is seeking patients for a clinical study of the device.
Holyoke Medical Center Weight Management Program is screening candidates in this area of the country to try the device, which is marketed under the trademark “Elipse.”
Those interested in the study must have a Body Mass Index of 30 or over, which is considered in the obesity range.
Allurion hopes the device, which is temporarily placed in the stomach to... read more} |
|
|
Mindray, a global medical equipment solution provider, announced the release of BeneVision N1 Patient Monitor. Designed for the varying demands of both intra and out-of-hospital patient transport, BeneVision N1 provides a steadfast and versatile solution that integrates seamlessly into the BeneVision Patient Monitoring Solution with maximum mobility, patient-centric data continuity and streamlined workflow. In compliance with... read more} |
|
The U.S. Food and Drug Administration (FDA) recently announced the publication of a 31-page set of guidelines for manufacturers producing medical products via 3D printing/additive manufacturing (AM). Although this information is presented as non-binding recommendations, the agency says it is the first in the world to provide such a comprehensive regulatory framework.
Titled “Technical Considerations for Additively Manufactured Medical Devices: Guidance for Industry and Food and Drug Administration Staff,” the document addresses... read more} |
|
Sensorion, a biotech company pioneering novel treatments for inner ear diseases, and Cochlear Limited, the global leader in implantable hearing solutions, today jointly announce a strategic collaboration focused on improving hearing outcomes in patients with cochlear implants. The collaboration will evaluate therapeutic approaches using SENS-401 in combination with cochlear implants, with preclinical studies initiating in 2018, and potential clinical trials to begin as soon as 2019. As part of this strategic collaboration, Cochlear will invest... read more} |
|
MiMedx Group, Inc., the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing proprietary human placental tissue allografts, today announced that it successfully settled the Company’s longstanding patent infringement lawsuit against Musculoskeletal Transplant Foundation, Inc. (“MTF”), Medline Industries, Inc. (“Medline”) and Liventa Bioscience, Inc. (“Liventa”).
In April 2014, MiMedx filed a lawsuit in the United States District Court for the Northern District of Georgia against MTF, Medline, and Liventa (formerly known as AFCell Medical, Inc.) for... read more} |
|
|
|
|